Investigational drug · Phase 2
CNMAu8
Also called: gold nanocrystals
Not approved by FDA. In 2 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Amyotrophic Lateral Sclerosis, Multiple Sclerosis.
Phase 2Last checked: Nov 19, 2026Latest source record: Dec 19, 2025 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
2
1 still active
All registered trials
4
Any phase or sponsor naming "CNMAu8"
First trial start
2019
Dec 19, 2019
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "CNMAu8", any sponsor or status.
Conditions studied
As listed on its trial records.
- Amyotrophic Lateral Sclerosis
- Multiple Sclerosis
Approved drugs for the same conditions: Multiple sclerosis · ALS (amyotrophic lateral sclerosis) · Neurology
Largest trials
Live from ClinicalTrials.gov: studies naming "CNMAu8" as an intervention, largest first.
Clene NanomedicineIndustry
NCT05299658 · 40 participants (planned) · Start Nov 13, 2021 · Primary completion Jun 2026
Drug: CNMAu8 · For: Amyotrophic Lateral Sclerosis
Sites: Concord, Australia; Randwick, Australia
- Intermediate Expanded Access Protocol CNMAu8.EAP04Temporarily not available
Clene NanomedicineIndustry
NCT06408727
Drug: CNM-Au8 · For: ALS; Amyotrophic Lateral Sclerosis; PALS
Sites: Fort Lauderdale, Florida; Chicago, Illinois; Iowa City, Iowa · 8 sites in all
Clene NanomedicineIndustry
NCT05281484
Drug: CNM-Au8 · For: Amyotrophic Lateral Sclerosis
Sites: Phoenix, Arizona; Orange, California; San Francisco, California · 16 sites in all
- Intermediate Expanded Access Protocol CNMAu8.EAP03Temporarily not available
Clene NanomedicineIndustry
NCT04081714
Drug: CNM-Au8 · For: Multiple Sclerosis
Sites: Dallas, Texas
Newest research
PubMed records naming it or its code names, newest first.
- Twinning by Controlled Cluster Coalescence: A Unified Pathway to Single-Crystalline, Single-Twinned, and Penta-Twinned Gold Nanocrystals.
Zhang H, Ding L, Lin X, et al. · Small 2026
- Solid-state laser refrigeration of nanoscale quantum sensors.
Feng Z, Pant A, Felsted RG, et al. · Proc Natl Acad Sci U S A 2026
- 4-ATP/CTAC-mediated morphology control of gold nanocrystals.
Yan X, Jia W, Yang Z, et al. · Chem Commun (Camb) 2026
- Capillary-integrated chiral gold nanocrystals for label-free SERS detection of serum amyloid-β 1-42 in Alzheimer's disease rats.
Zhou Y, Fu H, Chen K, et al. · Mikrochim Acta 2026
- Chirality-Induced One-Way Magnetoresistance in Gold Nanocrystals.
Wu F, Wang Y, Zhao Y, et al. · J Am Chem Soc 2026
- From Static Structures to Molecular Dynamics: Emerging Directions in X-Ray and Electron Materials Characterization.
Sasaki D, Mio K, Sasaki YC · Materials (Basel) 2026
Also in development for Amyotrophic Lateral Sclerosis
- MasitinibAB1010Phase 33 trials
AB Science · Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Alzheimer Disease
- SPG302TazbentetolPhase 33 trials
Spinogenix · Alzheimer Disease, Schizophrenia, Amyotrophic Lateral Sclerosis
- PridopidinePhase 32 trials
Prilenia · Amyotrophic Lateral Sclerosis, Huntington Disease
- ION363Phase 31 trial
Ionis Pharmaceuticals · Amyotrophic Lateral Sclerosis
- MN-166ibudilastPhase 31 trial
MediciNova · Amyotrophic Lateral Sclerosis
- AMT-162Phase 21 trial
UniQure Biopharma B.V. · Amyotrophic Lateral Sclerosis
- AP-101Phase 21 trial
AL-S Pharma · Amyotrophic Lateral Sclerosis
- BIIB147Phase 21 trial
Biogen · Amyotrophic Lateral Sclerosis
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.